Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Fondazione IRCCS Istituto Nazionale dei Tumori (National Cancer Institute) Milan, Italy


Alessandro Gronchi MD received his MD degree from Milan University with honours in 1992 and completed his residency training in General Surgery at the San Raffaele General Hospital, Milan.

He completed his training with a fellowship in Surgical Oncology at the National Cancer Institute, Milan in 1998 and later joined the faculty at the Department of Surgery at the National Cancer Institute, as attending surgeon in the Sarcoma Service. He has been Chair of the Sarcoma Service at the National Cancer Institute in Milan since 2001 and runs their Sarcoma database, which gathers clinical and biological information on over 8000 patients affected by STS, DF and GIST, treated over the past three decades in Milan.

As Principal Investigator on several international trials on STS, DF and GIST, Dr Gronchi’s research has focussed on neoadjuvant therapies in extremity and retroperitoneal sarcomas, new targets for specific STS subtypes, different telomere maintenance mechanisms in STS subtypes, genomic characterisation of DF and mechanisms of resistance to therapy in GIST.

He currently serves as Chairman of the Soft Tissue Sarcoma Committee of the Italian Sarcoma Group (ISG), Chair of the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group and President of the Connective Tissue Oncology Society (CTOS) 2016, member of the Board of Directors of the Italian Society of Surgical Oncology (SICO), the European Society for Medical Oncology (ESMO), the European Society of Surgical Oncology (ESSO), the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO). Dr Gronchi has authored more than 240 scientific publications, serves as Associate Editor of the Sarcoma Journal and was Sarcoma Section Editor of the Annals of Surgical Oncology 2009–2014.